Previous research has indicated that salvianolic acid A reverses cisplatin resistance by targeting c-met and attenuating the Akt–mTOR pathway in lung cancer [36] and salvianolic-acid-B-attenuated cisplatin-induced cardiac injury and oxidative stress by modulating the Nrf2 signal pathway. This evidence concerns the gene AKT1 and lung carcinoma.